ArriVent BioPharma, Inc Common Stock
Price & Volume
Stats
See moreOpen | $20.86 |
Previous Close | $20.82 |
Day Range | $20.76-$21.85 |
52W Range | $15.47-$36.37 |
Market Cap | $783.3M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4 |
News
See moreYahoo Finance • 17 days ago
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
Yahoo Finance • 2 months ago
ArriVent BioPharma Reports Second Quarter 2025 Financial Results
Yahoo Finance • 3 months ago
ArriVent expects topline data from lung cancer drug trial in early 2026
Yahoo Finance • 3 months ago
ArriVent BioPharma stock maintains Buy rating at Clear Street despite competitor approval
About
CEO | Dr. Zhengbin Yao Ph.D. |
CFO | Mr. Winston Kung M.B.A. |
Address | 18 Campus Boulevard, Newtown Square, PA, United States, 19073 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 52 |
